Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy-Reference-Cited by-同舟云学术

Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy

Published:2019-06 Issue:26 Volume:98 Page:e16235
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Chen Guan-Jhou,Sun Hsin-Yun,Cheng Aristine,Chuang Yu-Chung,Huang Yu-Shan,Lin Kuan-Yin,Huang Yi-Chia,Liu Wen-Chun,Wu Pei-Ying,Hung Chien-Ching,Chang Shan-Chwen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Raltegravir: molecular basis of its mechanism of action;Mouscadet;Eur J Med Res,2009

2. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA Panel;Saag;JAMA,2018

3. Sustained efficacy and safety of raltegravir after 5 years of combination antiretroviral therapy as initial treatment of HIV-1 infection: final results of a randomized, controlled, phase II study (Protocol 004);Gotuzzo;J Acquir Immune Defic Syndr(1999),2012

4. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials;Eron;Lancet Infect Dis,2013

5. Creatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study;Monteiro;J Antimicrob Chemother,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propolis Intake by People Living With HIV: Biochemical Profile, Nutritional Status, and Safety;Journal of Herbal Medicine;2024-02

2. Inflammatory Myositis Secondary to Anti-Retroviral Therapy in a Child; Case Report and Review of the Literature;Journal of Neuromuscular Diseases;2021-11-02

3. Nothing is perfect: the safety issues of integrase inhibitor regimens;Expert Opinion on Drug Safety;2020-05-22